These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 18950618)

  • 1. Ketanserin, a 5-HT2 receptor antagonist, decreases nicotine self-administration in rats.
    Levin ED; Slade S; Johnson M; Petro A; Horton K; Williams P; Rezvani AH; Rose JE
    Eur J Pharmacol; 2008 Dec; 600(1-3):93-7. PubMed ID: 18950618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ketanserin attenuates nicotine-induced working memory improvement in rats.
    Levin E; Icenogle L; Farzad A
    Pharmacol Biochem Behav; 2005 Oct; 82(2):289-92. PubMed ID: 16185760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Persistent attenuation of nicotine self-administration in rats by co-administration of chronic nicotine infusion with the dopamine D
    DiPalma D; Rezvani AH; Willette B; Wells C; Slade S; Hall BJ; Levin ED
    Pharmacol Biochem Behav; 2019 Jan; 176():16-22. PubMed ID: 30419272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nicotinic-serotonergic drug interactions and attentional performance in rats.
    Rezvani AH; Caldwell DP; Levin ED
    Psychopharmacology (Berl); 2005 May; 179(3):521-8. PubMed ID: 15682310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lorcaserin, a 5-HT2C agonist, decreases nicotine self-administration in female rats.
    Levin ED; Johnson JE; Slade S; Wells C; Cauley M; Petro A; Rose JE
    J Pharmacol Exp Ther; 2011 Sep; 338(3):890-6. PubMed ID: 21636655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cocaine acts on accumbens monoamines and locomotor behavior via a 5-HT2A/2C receptor mechanism as shown by ketanserin: 24-h follow-up studies.
    Broderick PA; Olabisi OA; Rahni DN; Zhou Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 May; 28(3):547-57. PubMed ID: 15093963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histamine H(1) antagonist treatment with pyrilamine reduces nicotine self-administration in rats.
    Levin ED; Slade S; Wells C; Pruitt M; Cousins V; Cauley M; Petro A; Hampton D; Rose J
    Eur J Pharmacol; 2011 Jan; 650(1):256-60. PubMed ID: 20951696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IV nicotine self-administration in rats using a consummatory operant licking response: sensitivity to serotonergic, glutaminergic and histaminergic drugs.
    Cousins V; Rose JE; Levin ED
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Oct; 54():200-5. PubMed ID: 24953434
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sazetidine-A, a selective alpha4beta2 nicotinic receptor desensitizing agent and partial agonist, reduces nicotine self-administration in rats.
    Levin ED; Rezvani AH; Xiao Y; Slade S; Cauley M; Wells C; Hampton D; Petro A; Rose JE; Brown ML; Paige MA; McDowell BE; Kellar KJ
    J Pharmacol Exp Ther; 2010 Mar; 332(3):933-9. PubMed ID: 20007754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurochemical and behavioral evidence that quipazine-ketanserin discrimination is mediated by serotonin2A receptor.
    Smith RL; Barrett RJ; Sanders-Bush E
    J Pharmacol Exp Ther; 1995 Nov; 275(2):1050-7. PubMed ID: 7473132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interactions of serotonin (5-HT)2 receptor-targeting ligands and nicotine: locomotor activity studies in rats.
    Zaniewska M; McCreary AC; Filip M
    Synapse; 2009 Aug; 63(8):653-61. PubMed ID: 19347958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of 5-HT2C receptor activation by WAY 161503 on nicotine-induced place conditioning and locomotor activity in rats.
    Hayes DJ; Mosher TM; Greenshaw AJ
    Behav Brain Res; 2009 Feb; 197(2):323-30. PubMed ID: 18805442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of acute systemic administration of serotonin2A/C receptor ligands in a delay-based decision-making task in rats.
    Hadamitzky M; Feja M; Becker T; Koch M
    Behav Pharmacol; 2009 Sep; 20(5-6):415-23. PubMed ID: 19730369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of nicotine cessation on the central serotonergic systems in mice: involvement of 5-HT(2) receptors.
    Yasuda K; Suemaru K; Araki H; Gomita Y
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Sep; 366(3):276-81. PubMed ID: 12172711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ejaculatory response induced by a 5-HT2 receptor agonist m-CPP in rats: differential roles of 5-HT2 receptor subtypes.
    Yonezawa A; Yoshizumi M; Ebiko M; Ise SN; Watanabe C; Mizoguchi H; Kimura Y; Sakurada S
    Pharmacol Biochem Behav; 2008 Feb; 88(4):367-73. PubMed ID: 17936345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Serotonin 2C Receptor Agonist Lorcaserin Attenuates Intracranial Self-Stimulation and Blocks the Reward-Enhancing Effects of Nicotine.
    Zeeb FD; Higgins GA; Fletcher PJ
    ACS Chem Neurosci; 2015 Jul; 6(7):1231-40. PubMed ID: 25781911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of 5-HT(2C) receptors reduces the locomotor and rewarding effects of nicotine.
    Grottick AJ; Corrigall WA; Higgins GA
    Psychopharmacology (Berl); 2001 Sep; 157(3):292-8. PubMed ID: 11605085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the 5-HT2C receptor agonist Ro60-0175 and the 5-HT2A receptor antagonist M100907 on nicotine self-administration and reinstatement.
    Fletcher PJ; Rizos Z; Noble K; Soko AD; Silenieks LB; Lê AD; Higgins GA
    Neuropharmacology; 2012 Jun; 62(7):2288-98. PubMed ID: 22342986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of administration of the nicotinic acetylcholine receptor antagonist BTMPS, during nicotine self-administration, on lever responding induced by context long after withdrawal.
    Hall BJ; Pearson LS; Buccafusco JJ
    Neuropharmacology; 2010 Feb; 58(2):429-35. PubMed ID: 19772864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repeated cocaine administration decreases 5-HT(2A) receptor-mediated serotonergic enhancement of synaptic activity in rat medial prefrontal cortex.
    Huang CC; Liang YC; Lee CC; Wu MY; Hsu KS
    Neuropsychopharmacology; 2009 Jul; 34(8):1979-92. PubMed ID: 19212317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.